Cargando…
Radiation-Induced Leiomyosarcoma: Does Antimetabolite Chemotherapy Contribute? A Report of Three Cases
Purpose: Radiation therapy in low and high doses is known to be associated with the occurrence of late secondary sarcomas. The addition of chemotherapy has not been clearly demonstrated as a contributing factor. We describe three patients with radiation-associated leiomyosarcoma who had also receive...
Autores principales: | Brockstein, Bruce, Mundt, Arno, Haraf, Daniel J., Ferguson, Mark, Montag, Anthony |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395527/ https://www.ncbi.nlm.nih.gov/pubmed/18521382 http://dx.doi.org/10.1080/13577140310001650330 |
Ejemplares similares
-
New antimetabolites in cancer chemotherapy and their clinical impact.
por: Kaye, S. B.
Publicado: (1998) -
Molecular features that predict the response to antimetabolite chemotherapies
por: Mehrmohamadi, Mahya, et al.
Publicado: (2017) -
A Study of Antimetabolites
Publicado: (1952) -
Problems in the Designing of Antimetabolites
por: Mautner, Henry G.
Publicado: (1960) -
Antimetabolite Treatment for Pancreatic Cancer
por: Valenzuela, Malyn May Asuncion, et al.
Publicado: (2014)